Amanote Research
Register
Sign In
P1.13-18 Exploring the Resistance Mechanism of Osimertinib and Monitoring the Treatment Response Using Plasma ctDNA in Chinese NSCLC Patients
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.875
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
Y. Shi
P. Xing
X. Han
S. Wang
Y. Liu
P. Liu
J. Li
L. Chang
Y. Guan
Z. Zhang
D. Wu
J. Yao
Y. Xin
Publisher
Elsevier BV